Echo, This is a mAb for cancers. It blocks the
Post# of 148167
This is a mAb for cancers. It blocks the immune suppressing activity by which the tumor cells evade targeting by the immune system.
Interesting and potentially very useful, but a different MOA from leronlimab with a tiny fraction of the clinical indications.
Plus it is preclinical.